BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 23 filers reported holding BAXTER INTL INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $811,108 | -17.0% | 22,089 | +2.7% | 0.01% | -12.5% |
| Q2 2023 | $977,091 | +39.0% | 21,504 | +24.1% | 0.01% | +14.3% |
| Q1 2023 | $703,079 | +128.8% | 17,334 | -16.1% | 0.01% | -53.3% |
| Q4 2022 | $307,350 | -71.6% | 20,669 | +2.8% | 0.02% | +25.0% |
| Q3 2022 | $1,083,000 | -38.1% | 20,109 | -26.2% | 0.01% | -25.0% |
| Q2 2022 | $1,751,000 | -20.4% | 27,255 | -3.9% | 0.02% | -5.9% |
| Q1 2022 | $2,199,000 | +2.8% | 28,366 | +13.8% | 0.02% | +6.2% |
| Q4 2021 | $2,139,000 | -27.2% | 24,922 | -31.8% | 0.02% | -15.8% |
| Q3 2021 | $2,938,000 | +84.3% | 36,536 | +84.5% | 0.02% | +35.7% |
| Q2 2021 | $1,594,000 | -4.7% | 19,806 | -0.1% | 0.01% | -12.5% |
| Q1 2021 | $1,672,000 | -3.1% | 19,818 | -7.8% | 0.02% | -11.1% |
| Q4 2020 | $1,725,000 | -5.7% | 21,495 | -3.0% | 0.02% | -25.0% |
| Q3 2020 | $1,830,000 | -36.9% | 22,156 | -34.2% | 0.02% | -40.0% |
| Q2 2020 | $2,900,000 | -6.5% | 33,677 | -11.8% | 0.04% | -29.8% |
| Q1 2020 | $3,101,000 | +1.4% | 38,193 | +4.4% | 0.06% | +18.8% |
| Q4 2019 | $3,059,000 | +9.1% | 36,588 | +12.0% | 0.05% | +9.1% |
| Q3 2019 | $2,803,000 | +28.5% | 32,680 | +22.6% | 0.04% | +12.8% |
| Q2 2019 | $2,182,000 | -43.0% | 26,645 | -43.5% | 0.04% | -48.7% |
| Q1 2019 | $3,831,000 | +148.4% | 47,129 | +101.1% | 0.08% | +105.4% |
| Q4 2018 | $1,542,000 | -27.1% | 23,431 | -14.6% | 0.04% | -14.0% |
| Q3 2018 | $2,116,000 | -1.9% | 27,446 | -6.2% | 0.04% | +22.9% |
| Q2 2018 | $2,158,000 | +147.2% | 29,246 | +117.9% | 0.04% | +2.9% |
| Q1 2018 | $873,000 | -54.8% | 13,419 | -52.0% | 0.03% | -58.5% |
| Q4 2017 | $1,932,000 | -21.7% | 27,985 | -30.3% | 0.08% | +34.4% |
| Q3 2017 | $2,468,000 | +27.7% | 40,131 | +25.7% | 0.06% | +17.3% |
| Q2 2017 | $1,933,000 | -6.1% | 31,930 | -60.3% | 0.05% | -10.3% |
| Q1 2017 | $2,058,000 | +38.4% | 80,356 | +153.4% | 0.06% | +18.4% |
| Q4 2016 | $1,487,000 | +4.8% | 31,709 | +5.7% | 0.05% | -15.5% |
| Q3 2016 | $1,419,000 | +18.0% | 29,993 | +15.1% | 0.06% | +18.4% |
| Q2 2016 | $1,203,000 | +24.5% | 26,066 | +11.5% | 0.05% | +4.3% |
| Q1 2016 | $966,000 | +1.4% | 23,381 | -6.4% | 0.05% | +2.2% |
| Q4 2015 | $953,000 | +28.1% | 24,990 | +10.2% | 0.05% | +12.2% |
| Q3 2015 | $744,000 | -48.7% | 22,672 | +9.3% | 0.04% | -40.6% |
| Q2 2015 | $1,450,000 | +12.1% | 20,742 | +9.8% | 0.07% | -8.0% |
| Q1 2015 | $1,294,000 | +13.4% | 18,897 | +19.9% | 0.08% | +2.7% |
| Q4 2014 | $1,141,000 | +20.7% | 15,759 | +19.7% | 0.07% | +12.3% |
| Q3 2014 | $945,000 | +16.7% | 13,167 | +17.5% | 0.06% | -7.1% |
| Q2 2014 | $810,000 | +19.5% | 11,205 | +21.6% | 0.07% | -1.4% |
| Q1 2014 | $678,000 | +19.4% | 9,214 | +12.7% | 0.07% | +12.7% |
| Q4 2013 | $568,000 | – | 8,173 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |